Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy

NCT05204394 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: VM-1500A-LAI
OTHER: Standard of Care

Sponsor

Viriom